tiprankstipranks
Advertisement
Advertisement

AU:PYC Stock Latest News

PYC Therapeutics Cuts Option Overhang as Multiple Incentive Securities Lapse
Company AnnouncementsPYC Therapeutics Cuts Option Overhang as Multiple Incentive Securities Lapse
10d ago
PYC
PYC to unveil early clinical data on first-in-class gene-targeted eye drugs at ARVO
PremiumCompany Announcements
PYC to unveil early clinical data on first-in-class gene-targeted eye drugs at ARVO
18d ago
PYC
PYC Therapeutics Issues New Shares Following Option Exercise and Lodges Cleansing Notice
PremiumCompany Announcements
PYC Therapeutics Issues New Shares Following Option Exercise and Lodges Cleansing Notice
23d ago
PYC
PYC Therapeutics Lists Additional 250,000 Shares on ASX
PremiumCompany Announcements
PYC Therapeutics Lists Additional 250,000 Shares on ASX
23d ago
PYC
PYC Therapeutics Advances Genetic Disease Pipeline After $600m Capital Raise
PremiumCompany Announcements
PYC Therapeutics Advances Genetic Disease Pipeline After $600m Capital Raise
24d ago
PYC
PYC Wins EMA Orphan Status for RP11 Gene Therapy Candidate VP-001
PremiumCompany AnnouncementsPYC Wins EMA Orphan Status for RP11 Gene Therapy Candidate VP-001
25d ago
PYC
PYC Therapeutics Wins Safety Nod to Advance ADOA Drug PYC-001 to Multi-Dose Trial
Premium
Company Announcements
PYC Therapeutics Wins Safety Nod to Advance ADOA Drug PYC-001 to Multi-Dose Trial
1M ago
PYC
PYC Therapeutics CEO Increases Shareholding and Receives Major Option Grant
Premium
Company Announcements
PYC Therapeutics CEO Increases Shareholding and Receives Major Option Grant
2M ago
PYC
PYC Therapeutics to Showcase PKD Drug Progress at World Nephrology Congress
PremiumCompany Announcements
PYC Therapeutics to Showcase PKD Drug Progress at World Nephrology Congress
2M ago
PYC
PYC Therapeutics Advances ADOA Drug PYC-001 With New Clinical Data and Ongoing Trial
PremiumCompany Announcements
PYC Therapeutics Advances ADOA Drug PYC-001 With New Clinical Data and Ongoing Trial
2M ago
PYC
PYC Therapeutics: Strengthened Balance Sheet and Expanded Development Plan Underpin Continued Buy Rating
PremiumRatings
PYC Therapeutics: Strengthened Balance Sheet and Expanded Development Plan Underpin Continued Buy Rating
2M ago
PYC Therapeutics CEO Increases Shareholding and Awaits Approval for New Options Grant
PremiumCompany Announcements
PYC Therapeutics CEO Increases Shareholding and Awaits Approval for New Options Grant
2M ago
PYC
PYC Therapeutics Seeks ASX Quotation for Over 10.5 Million New Shares
PremiumCompany AnnouncementsPYC Therapeutics Seeks ASX Quotation for Over 10.5 Million New Shares
2M ago
PYC
PYC Therapeutics Seeks ASX Quotation for Over 31 Million New Shares
Premium
Company Announcements
PYC Therapeutics Seeks ASX Quotation for Over 31 Million New Shares
3M ago
PYC
PYC Therapeutics appoints new joint company secretary to oversee ASX compliance
Premium
Company Announcements
PYC Therapeutics appoints new joint company secretary to oversee ASX compliance
3M ago
PYC
PYC Therapeutics Completes $47m Retail Entitlement Offer, Boosting Capital for RNA Programs
PremiumCompany Announcements
PYC Therapeutics Completes $47m Retail Entitlement Offer, Boosting Capital for RNA Programs
3M ago
PYC
PYC Therapeutics Issues Cautious Q1 2026 Investor Update
PremiumCompany Announcements
PYC Therapeutics Issues Cautious Q1 2026 Investor Update
3M ago
PYC
PYC Therapeutics Files Interim Results as RNA Pipeline Advances
PremiumCompany Announcements
PYC Therapeutics Files Interim Results as RNA Pipeline Advances
3M ago
PYC
PYC Therapeutics Seeks ASX Quotation for 354.8 Million New Shares
PremiumCompany Announcements
PYC Therapeutics Seeks ASX Quotation for 354.8 Million New Shares
3M ago
PYC
PYC Therapeutics Opens Retail Entitlement Offer to Fund RNA Therapy Pipeline
PremiumCompany AnnouncementsPYC Therapeutics Opens Retail Entitlement Offer to Fund RNA Therapy Pipeline
3M ago
PYC
PYC Therapeutics launches major entitlement offer and placement to fund RNA therapy programs
Premium
Company Announcements
PYC Therapeutics launches major entitlement offer and placement to fund RNA therapy programs
3M ago
PYC
PYC Therapeutics Opens Retail Component of Entitlement Offer to Fund RNA Therapy Pipeline
Premium
Company Announcements
PYC Therapeutics Opens Retail Component of Entitlement Offer to Fund RNA Therapy Pipeline
3M ago
PYC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >